Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadja Baur

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biomedical Microdevices|October 5, 2013
Moving the solid phase: a platform technology for cartridge based sandwich immunoassaysRaiah Gottheil, Nadja Baur, Holger Becker, et al.
International Immunopharmacology|October 30, 2012
Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole bloodMichael Schmohl, Nicole Schneiderhan-Marra, Nadja Baur, et al.
Cancer Causes & Control : CCC|September 17, 2014
Plasma matrix metalloproteinase 1, 3, and 7 levels and breast cancer risk in the Nurses' Health studySarah A Aroner, Bernard A Rosner, Rulla M Tamimi, et al.
Cancer Epidemiology|March 25, 2015
Plasma matrix metalloproteinase 2 levels and breast cancer riskSarah A Aroner, Bernard A Rosner, Rulla M Tamimi, et al.
Neuroendocrinology|July 25, 2018
Increased Energy Expenditure, Lipolysis and Hyperinsulinemia Confer Resistance to Central Obesity and Type 2 Diabetes in Mice Lacking Alpha2α-AdrenoceptorsSuvi T Ruohonen, Laura Valve, Katja Tuomainen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biomedical Microdevices|October 5, 2013
Moving the solid phase: a platform technology for cartridge based sandwich immunoassaysRaiah Gottheil, Nadja Baur, Holger Becker, et al.
International Immunopharmacology|October 30, 2012
Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole bloodMichael Schmohl, Nicole Schneiderhan-Marra, Nadja Baur, et al.
Cancer Causes & Control : CCC|September 17, 2014
Plasma matrix metalloproteinase 1, 3, and 7 levels and breast cancer risk in the Nurses' Health studySarah A Aroner, Bernard A Rosner, Rulla M Tamimi, et al.
Cancer Epidemiology|March 25, 2015
Plasma matrix metalloproteinase 2 levels and breast cancer riskSarah A Aroner, Bernard A Rosner, Rulla M Tamimi, et al.
Neuroendocrinology|July 25, 2018
Increased Energy Expenditure, Lipolysis and Hyperinsulinemia Confer Resistance to Central Obesity and Type 2 Diabetes in Mice Lacking Alpha2α-AdrenoceptorsSuvi T Ruohonen, Laura Valve, Katja Tuomainen, et al.
Pageof 1